Connecticut Venture Group conference spotlights Yale spin-off companies

November 30, 2005

Several local companies whose technologies are an outgrowth of Yale research will be featured at TechComm III - The 3rd Annual Technology Commercialization Conference & Exhibition to be held Thursday, December 8, from 8:30 a.m. to 2:00 p.m. at the Omni New Haven Hotel at Yale.

The program will be keynoted by Roger Longman, a Managing Partner at Windhover Information Inc., who has been involved with the health care industry for more than 20 years. Experienced in providing qualified information on innovative technologies, start-up companies, and the latest investment trends, he will speak on trends in technology commercialization and challenges for Connecticut.

"It is exciting to see the acceleration of technology moving from the Yale 'benchtop' to local commercial success," said Jon Soderstrom, managing director of the Office of Cooperative Research at Yale.

Panel sessions will focus on "Early Stage Development - Strategies for surviving from Eureka! through product development" and on "Later Stage Development - Product development through partnerships." Exhibits by sponsoring and featured companies will be available beginning at the break between panel sessions.

The first panel will include Mark Velleca, M.D. Chief Scientific Officer of CGI Pharmaceuticals in Branford, a drug discovery company whose products are based on technology developed with Ira Mellman, Sterling Professor and Chair of Genetics at Yale. It will also feature Sean Glass, the Chief Marketing Officer of Higher One, a company at 25 Science Park at Yale founded by Yale College students to provide refund management services to higher education institutions.

Achillion Pharmaceuticals, located at 300 George Street, New Haven, will be represented in the second panel by Michael D. Kishbauch, its President and CEO. Achillion was founded in 2000 as an outgrowth of technology developed by Yung-Chi (Tommy) Cheng, Henry Bronson Professor of Pharmacology at Yale to develop treatments for infectious disease.
A complete program of the conference is available online at or by contacting Catherine Koh at or 203-785-3141. Registration (at is free to students and faculty, members of Yale, UConn, CVG, CURE, CCAT staff; and by reservation and with a fee for others.

Yale University

Related Product Development Articles from Brightsurf:

How anxiety--and hope--can drive new product adoption
When considering new products, anxiety creates approach response (i.e., interest, purchase) rather than avoidance response (i.e., disinterest, failure to purchase) when consumers hope for the goal-congruent outcomes.

Product recommendation systems can help with search of antiviral drugs
Scientists from Skoltech and the Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of RAS checked the ability of artificial intelligence that suggest products to buy, recommend new antiviral compounds.

Chemical recycling makes useful product from waste bioplastic
A faster, more efficient way of recycling plant-based 'bioplastics' has been developed by a team of scientists at the universities of Birmingham and Bath.

Insulins available at US pharmacies are consistent with product labeling
Funding partners JDRF, the American Diabetes Association (ADA), and The Leona M. and Harry B.

Promoting advantages of product category, such as e-cigarettes, can backfire
Researchers suggest that during the past decade, efforts to promote e-cigarettes as a healthier alternative to combustible cigarettes backfired.

Highlighting product greenness may put consumers off buying
New research suggests that companies looking to promote their latest environmentally friendly product should downplay its green credentials if they want consumers to buy it.

Product distribution restraints are not equal research shows
Online shoppers may be pleasantly surprised to find the price of their chosen item has dropped once they've moved to the checkout phase of their purchase.

Towards sustainability -- from a by-product of the biodiesel industry to a valuable chemical
Scientists at Tokyo Institute of Technology (Tokyo Tech) and the National Taiwan University of Science and Technology (Taiwan Tech) develop a cheap and efficient copper-based catalyst that can be used to convert glycerol, one of the main by-products of the biodiesel industry, into a valuable compound called dihydroxyacetone.

Value chain collaboration in new product development yields innovativeness and performance
Businesses looking for a cutting edge in new products find greater innovativeness and better performance of both product and company overall when working with other firms in the same value chain.

Consumers trust influencers less when there is a variety of choices for a product
Consumers have been relying on opinion leader recommendations to make choices about product quality and purchases for a long time.

Read More: Product Development News and Product Development Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to